Yasuki Hori Selected Research

Self Expandable Metallic Stents

1/2022	Practical Experiences of Unsuccessful Hemostasis with Covered Self-Expandable Metal Stent Placement for Post-Endoscopic Sphincterotomy Bleeding.
10/2021	A pilot study of novel duodenal covered self-expandable metal stent fixation.
12/2019	Feasibility and safety of duodenal covered self-expandable metallic stent fixation: an experimental study.
10/2018	The utility and efficacy of self-expandable metal stents for treating malignant gastric outlet obstructions in patients under best supportive care.
10/2017	Predictors of stent dysfunction after self-expandable metal stent placement for malignant gastric outlet obstruction: tumor ingrowth in uncovered stents and migration of covered stents.
2/2017	Predictors of outcomes in patients undergoing covered and uncovered self-expandable metal stent placement for malignant gastric outlet obstruction: a multicenter study.
8/2015	Stent under-expansion on the procedure day, a predictive factor for poor oral intake after metallic stenting for gastric outlet obstruction.
7/2015	Safety and benefits of self-expandable metallic stents with chemotherapy for malignant gastric outlet obstruction.
4/2015	Case of arterial hemorrhage after endoscopic papillary large balloon dilation for choledocholithiases using a covered self-expandable metallic stent.
1/2013	Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuki Hori Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 01/2015
7	Gastric Outlet Obstruction 10/2021 - 07/2015
6	Pathologic Constriction (Stenosis) 06/2021 - 01/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2015
3	Adenocarcinoma 01/2022 - 01/2015
3	Ascites 02/2021 - 01/2017
3	Chronic Pancreatitis 01/2021 - 01/2015
2	Hemorrhage 01/2022 - 04/2015
2	Pancreatitis 01/2022 - 01/2013
2	Inflammation (Inflammations) 01/2019 - 01/2014
2	Autoimmune Pancreatitis 06/2018 - 01/2015
1	Sclerosing Cholangitis 06/2021
1	Mediastinitis 01/2021
1	Pneumonia (Pneumonitis) 10/2018
1	Obstructive Jaundice (Cholestatic Jaundice) 06/2018
1	Jaundice (Icterus) 06/2018
1	Autoimmune Diseases (Autoimmune Disease) 06/2018
1	Cushing Syndrome 07/2016
1	Neuroendocrine Carcinoma 07/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2016
1	Hypokalemia 07/2016
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2016
1	Carcinogenesis 12/2015
1	Cholangiocarcinoma 01/2015
1	Disease Progression 01/2015
1	Shock 07/2014
1	Cholangitis 01/2014
1	Hyperthermia 07/2013
1	Cholecystitis 01/2013
1	Stomach Neoplasms (Stomach Cancer) 10/2009

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 02/2021 - 01/2014
2	Immunoglobulin G (IgG)IBA 06/2018 - 04/2015
2	Talaporfin (talaporfin sodium)IBA 01/2017 - 01/2015
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2017 - 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	taxaneIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	TubulinIBA 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	folfirinoxIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 06/2021
1	6- (3- (piperazin- 1- yl)propanoyl)benzo(d)oxazol- 2(3H)- oneIBA 02/2021
1	LipidsIBA 02/2021
1	Biological ProductsIBA 02/2021
1	lysophosphatidic acidIBA 02/2021
1	Bile Pigments (Bilin)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	NitrogenIBA 01/2019
1	Urea (Carbamide)FDA LinkGeneric 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	chlorinIBA 01/2017
1	maltotrioseIBA 01/2017
1	Photosensitizing Agents (Photosensitizers)IBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2016
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2016
1	SynaptophysinIBA 07/2016
1	Chromogranin AIBA 07/2016
1	BilirubinIBA 01/2016
1	Cyclin D1IBA 12/2015
1	PhytochemicalsIBA 12/2015
1	acetovanillone (apocynin)IBA 12/2015
1	ResveratrolIBA 12/2015
1	antineoplaston A10 (A 10)IBA 04/2015
1	ParaffinIBA 01/2015
1	Formaldehyde (Formol)FDA Link 01/2015
1	Codon (Codons)IBA 01/2015
1	SteroidsIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Proto-Oncogene Proteins c-mdm2IBA 01/2015
1	PlasticsIBA 01/2014
1	Pharmaceutical PreparationsIBA 07/2013
1	MetalsIBA 01/2013
1	Docetaxel (Taxotere)FDA Link 10/2009

Therapy/Procedure

10	Self Expandable Metallic Stents 01/2022 - 01/2013
10	Stents 10/2021 - 01/2014
8	Therapeutics 01/2022 - 10/2009
2	Endoscopic Hemostasis 01/2022 - 04/2015
2	Surgical Instruments (Clip) 03/2018 - 01/2016
2	Photochemotherapy (Photodynamic Therapy) 01/2017 - 01/2015
1	Endoscopic Sphincterotomy 01/2022
1	Traction 05/2017
1	Palliative Care (Palliative Therapy) 02/2017
1	Drug Therapy (Chemotherapy) 07/2015
1	Catheters 04/2015
1	Duration of Therapy 07/2014
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 07/2014
1	Cholecystectomy 01/2013